503040-75-3 Usage
General Description
2,5-Benzothiazolediamine,N2-methyl-(9CI) is a chemical compound with the molecular formula C8H9N3S. It is a derivative of benzothiazole and is commonly used in the production of various polymers and dyes. 2,5-Benzothiazolediamine,N2-methyl-(9CI) is also used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. 2,5-Benzothiazolediamine,N2-methyl-(9CI) is classified as a hazardous substance and has potential health risks associated with its handling and exposure. Proper safety precautions should be taken when working with this chemical to minimize the risk of harm to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 503040-75-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,0,4 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 503040-75:
(8*5)+(7*0)+(6*3)+(5*0)+(4*4)+(3*0)+(2*7)+(1*5)=93
93 % 10 = 3
So 503040-75-3 is a valid CAS Registry Number.
503040-75-3Relevant academic research and scientific papers
Inhibitors of histone deacetylase
-
, (2008/06/13)
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
Inhibitors of histone deacetylase
-
, (2008/06/13)
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
Inhibitors of histone deacetylase
-
, (2008/06/13)
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
